You can now view the recording of our webinar - Radical cure of vivax malaria: can we do better?
The three presentations and expert discussion, chaired by Professor Sir Nicholas White (Mahidol Oxford Research Unit) and Dr Chau Nguyen Hoang (Oxford University Clinical Research Unit), are now available on our YouTube channel @IDDOandWWARN. You can watch the full, partially captioned event here.
The webinar took place earlier this month and featured two new studies using WWARN-hosted clinical trial data showing that the dosing of the 8-aminoquinolin drugs primaquine and tafenoquine can be substantially improved. These analyses include the majority of all studied vivax malaria patients who received 8-aminoquinoline drugs over the last 20 years. Laboratory work confirms these findings and provides important new information on the mechanism of action of these essential medicines.
Videos of the three webinar presentations can also be linked to directly:
- Dr Alison Roth, Walter Reed Army Institute of Research, on laboratory studies assessing hypnozoitocidal activity
- Dr James Watson, Oxford University Clinical Research Unit, on the reassessment of tafenoquine pharmacometrics
Read the paper The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis
To stay up to date with our research, sign up to our IDDO newsletter or for more information about our work in malaria, sign up to the WWARN newsletter.